Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Prichard

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Chromatography|December 9, 1983
Simultaneous high-performance liquid chromatographic analysis of omeprazole and its sulphone and sulphide metabolites in human plasma and urineG W Mihaly, P J Prichard, R A Smallwood, et al.
Clinics and Research in Hepatology and Gastroenterology|April 20, 2011
Type 2 diabetes does not worsen prognosis in hepatocellular carcinomaJ Howell, M Yiu, R Gibson, et al.
British Journal of Clinical Pharmacology|December 1, 1986
The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapyP J Prichard, D B Jones, N D Yeomans, et al.
British Medical Journal (Clinical Research Ed.)|November 5, 1983
Effect of daily oral omeprazole on 24 hour intragastric acidityP J Prichard, N D Yeomans, G W Mihaly, et al.
British Journal of Clinical Pharmacology|October 1, 1987
Oral phenytoin pharmacokinetics during omeprazole therapyP J Prichard, R P Walt, G K Kitchingman, et al.
The Medical Journal of Australia|December 7, 1992
Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleedingR O Day, D A Henry, K D Muirden, et al.
British Medical Journal (Clinical Research Ed.)|February 23, 1985
Double blind comparative study of omeprazole 10 mg and 30 mg daily for healing duodenal ulcersP J Prichard, D Rubinstein, D B Jones, et al.
Gastroenterology|January 1, 1985
Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosageP J Prichard, N D Yeomans, G W Mihaly, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Chromatography|December 9, 1983
Simultaneous high-performance liquid chromatographic analysis of omeprazole and its sulphone and sulphide metabolites in human plasma and urineG W Mihaly, P J Prichard, R A Smallwood, et al.
Clinics and Research in Hepatology and Gastroenterology|April 20, 2011
Type 2 diabetes does not worsen prognosis in hepatocellular carcinomaJ Howell, M Yiu, R Gibson, et al.
British Journal of Clinical Pharmacology|December 1, 1986
The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapyP J Prichard, D B Jones, N D Yeomans, et al.
British Medical Journal (Clinical Research Ed.)|November 5, 1983
Effect of daily oral omeprazole on 24 hour intragastric acidityP J Prichard, N D Yeomans, G W Mihaly, et al.
British Journal of Clinical Pharmacology|October 1, 1987
Oral phenytoin pharmacokinetics during omeprazole therapyP J Prichard, R P Walt, G K Kitchingman, et al.
The Medical Journal of Australia|December 7, 1992
Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleedingR O Day, D A Henry, K D Muirden, et al.
British Medical Journal (Clinical Research Ed.)|February 23, 1985
Double blind comparative study of omeprazole 10 mg and 30 mg daily for healing duodenal ulcersP J Prichard, D Rubinstein, D B Jones, et al.
Gastroenterology|January 1, 1985
Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosageP J Prichard, N D Yeomans, G W Mihaly, et al.
Pageof 2